Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Apellix is a drug used to treat certain types of breast cancer, and its use, storage, and drug interactions require strict attention from patients and health care providers.What in···【more】
Article source：Captain MedicineRelease date：2024-12-23Recommended：306
Apellix is a therapeutic drug that targets specific types of breast cancer, and its complex pharmacological properties and strict conditions of use are critical for patients.What a···【more】
Article source：Captain MedicineRelease date：2024-12-23Recommended：302
Apellix is a drug used to treat specific types of breast cancer, and its use, storage, and daily precautions are critical for patients.Which drugs interact with AlpelisibInteractio···【more】
Article source：Captain MedicineRelease date：2024-12-23Recommended：311
Apelix is a drug for the treatment of specific diseases, and special attention should be paid to safety and effectiveness in its use.What to look out for when using AlpelisibAlpeli···【more】
Article source：Captain MedicineRelease date：2024-12-20Recommended：311
Apelix is a drug that requires special attention to possible adverse skin reactions during its use. Understanding these precautions and countermeasures is critical to ensuring the ···【more】
Article source：Captain MedicineRelease date：2024-12-20Recommended：277
Apelix is a drug that requires special attention to possible adverse skin reactions during its use. Understanding these precautions and countermeasures is critical to ensuring the ···【more】
Article source：Captain MedicineRelease date：2024-12-20Recommended：284
Alpelisib is an inhibitor targeting PI3Kα and is mainly used to treat specific types of breast cancer. This article will elaborate on the precautions of the use of apellix, adverse···【more】
Article source：Captain MedicineRelease date：2024-12-20Recommended：305
The purpose of this article is to provide comprehensive guidance for patients and healthcare professionals by providing an in-depth discussion of the side effects of alpelisib, the···【more】
Article source：Captain MedicineRelease date：2024-12-20Recommended：289
Apellix is a drug that targets the PI3Kα pathway, providing a new treatment option for breast cancer patients, but its side effects and coping methods have become the focus of pati···【more】
Article source：Captain MedicineRelease date：2024-12-20Recommended：242
Alpelisib, an innovative targeted therapy drug, brings new hope for specific types of breast cancer patients. However, like many powerful drugs, apellix can be accompanied by a ran···【more】
Article source：Captain MedicineRelease date：2024-12-20Recommended：272
Apelix is a common drug that is widely used in a variety of health management fields. Knowing the right dosage can ensure that your medication is working as well as it should. The ···【more】
Article source：Captain MedicineRelease date：2024-12-19Recommended：265
Apelix is a commonly used drug that is widely used in a variety of health management fields. Proper use can help patients better achieve their treatment goals. Understanding how Ap···【more】
Article source：Captain MedicineRelease date：2024-12-19Recommended：257
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：4462025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：6352024-09-07
On May 28, 2026, AstraZeneca announced that its immunotherapy drug Imfinzi (durvalumab) in combinati···【more】
Recommended：902026-01-06
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：4142025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：4322025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：4172025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：4732025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：3832025-01-12
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
